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Stiff-stilbene ligands target G-quadruplex DNA and exhibit 
selective anticancer and antiparasitic activity 
Michael P. O’Hagan[a], Pablo Peñalver[b], Rosina S. L. Gibson[a], Juan C. Morales*[b] and M. Carmen 
Galan* 
 
Abstract: G-quadruplex nucleic acid structures have long been 
studied as potential anticancer targets while their potential in 
antiparasitic therapy has only recently been recognized but barely 
explored. Herein we report the synthesis, biophysical characterization 
and in vitro screening of a series of stiff-stilbene G4 binding ligands 
featuring differing electronics, side-chain chemistries and molecular 
geometries. The ligands display selectivity for G4 DNA over duplex 
DNA and exhibit nanomolar toxicity against Trypasanoma brucei and 
HeLa cancer cells whist remaining up to two orders of magnitude less 
toxic to non-tumoral mammalian cell line MRC5. Our study 
demonstrates that stiff-stilbenes show exciting potential as the basis 
of selective anticancer and antiparasitic therapies. In order to achieve 
the most efficient G4 recognition the scaffold must possess the 
optimal electronics and substitution pattern and correct molecular 
configuration.  
Introduction 
G-quadruplexes (G4) are a class of nucleic acid secondary 
structure that form from sequences rich in guanine. In contrast to 
the classical duplex structure stabilized by Watson-Crick base 
pairing, the nucleic acid strand folds to create a stacked 
arrangement of G-tetrads, square-planar ensembles of four 
guanine residues stabilized by Hoogsteen hydrogen bonding and 
coordination to a central cation, such as Na+ or K+.[1] These 
structures receive significant attention as potential therapeutic 
targets.[2] Of particular interest is the quadruplex formed by the 
human telomeric sequence; telomerase expression is 
upregulated in cancer cells and partly responsible for cellular 
immortality by preventing telomere shortening, leading to 
uncontrolled proliferation.[2–4] Furthermore, G4s are found in the 
promoter regions of several genes associated with the 
development of cancer (e.g. c-myc,[5] BCL2[6] and c-kit[7]), where 
stabilization of the folded G4 by ligands is proposed to inhibit the 
binding of transcription factors leading to downstream silencing of 
oncogene expression.[8] More recently, we reported the 
identification of putative G4-forming sequences in the genomes of 
the protazoan parasites Trypanosoma brucei and Leishmania 
major.[9] Both organisms contain frequent occurrences of the 
human telomeric sequence[10] in addition to several further unique 
G4s. For example, the EBR1 sequence occurs 33 times in the T. 
brucei genome and was subsequently demonstrated to form a 
stable quadruplex under physiological conditions in biophysical 
studies. The sequence predominately occurs in genomic regions 
coding for several proteins including a cysteine peptidase and a 
purine transporter.[9] G4s therefore present a potential opportunity 
as a target for novel antiparasitic therapies, for which there is an 
urgent need for further development.[11] The T. brucei parasite, 
responsible for the Human African Trypanosomiasis (HAT) 
disease, endangers 69 million people across Sub-Saharan 
Africa,[12,13] and existing therapies suffer from severe limitations 
including severe side effects[14] and emerging drug resistance[15] 
in the parasitic strains. G4 ligands have long been studied as the 
basis of anticancer and antiviral therapeutics, but their potential 
as antiparasitic agents has been neglected until recently.[9,16] The 
handful of compounds explored to date are primarily naphthalene 
diimide derivatives, already widely studied as the basis of 
potential anticancer drugs. Though the activities are promising, 
the identification of further DNA-binding chemotypes capable of 
exerting selective antiparasitic activity is of critical relevance to 
exploring this therapeutic hypothesis. In a recent study, we 
identified a novel G4-binding chemotype derived from stiff-
stilbene, (E)-1, the first example of a G4 ligand derived from this 
scaffold.[17] Whilst ligand 1 induces high thermal stabilization of 
the potassium form of human telomeric DNA, the same compound 
causes the unfolding of the antiparallel form of the same 
sequence formed in sodium buffer. These intriguing activities 
suggested stiff-stilbene as a promising scaffold for the design of 
potent and selective G4-binding agents, prompting us to consider 
the potential applications of these derivatives as anticancer and 
antiparasitic agents. Towards this end, we synthesized further 
analogues of the previously reported compound and investigated 
the binding of these new derivatives using FRET thermal melting 
assay to a small library of G4 DNA sequences that are relevant in 
the targeting of cancers and parasitic infections. Binding was 
additionally validated through circular dichroism spectroscopy 
and UV-visible titration studies. We then took initial steps to 
validate the therapeutic utility of these compounds by examining 
their toxicity and localization (intracellular uptake) in parasitic 
cultures and mammalian cells. Our results suggest a striking 
selectivity of the lead compounds for the target pathologies and 
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recommend this class of DNA-binding molecule as a candidate 
for further development of a new generation of anticancer and 
antiparasitic therapeutic leads. 
Results and Discussion 
Design and synthesis of stiff-stilbene ligands 
In order to evaluate the effect of ligand structure on the G4 binding 
properties and antiproliferative activities of stiff stilbene ligands, 
we prepared a small collection of compounds designed to 
investigate these effects (Figure 1). These derivatives incorporate 
a variety of stilbene stereochemical configuration, electronic 
effects, substitution pattern, and length and nature of lateral 
groups. In particular, we were keen to examine the effect of 
exchanging the rigid methylpyridinium moiety in the previously 
reported compounds (1 and 2) for a more flexible amine-derived 
side-chain (compounds 4 and 5), previously demonstrated by 
several groups to confer good G4 affinity by forming electrostatic 
interactions with the G4 grooves when protonated at physiological 
pH.[18,19] Meanwhile, the relocation of the pyridinium group to an 
alternative position on the scaffold (compound 3) significantly 
alters the ligand shape from a more compact S-shaped molecule 
to an extended linear structure, potentially influencing the ability 
to interact with G-tetrads as well as significantly altering the 
electronic structure of the molecule. Finally, we were keen to 
further examine the effects of the configuration of the central 
stilbene core on G4 binding and in vitro activity by a more detailed 
comparison of the E and Z forms of the ligands (1 vs 2 and 4 vs 
 
Figure 1: Structures of the stiff-stilbene G4 ligands studied in this work. 
 
Scheme 1: General synthetic route to stiff-stilbene G4 ligands. 
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5). With routes to compounds 1 and 2 already established,[17] 
related ligand 3 was synthesized using an analogous protocol 
(Scheme 1). Briefly, McMurry coupling of 5-bromoindanone m-6 
afforded bromide p-7 which was coupled to 4-pyridylboronic acid 
8 using standard Suzuki conditions to afford intermediate p-(E)-9. 
Methylation proceeded smoothly to afford compound 3 which was 
easily purified by trituration in acetone. Preparation of 
methylpiperazine analogues 4 and 5 proceeded straightforwardly 
by Buchwald-Hartwig amination of bromides m-(E)-7 and m-(Z)-7 
with 1-(3-aminopropyl)-4-methylpiperazine, and the desired 
compounds 4 and 5 were obtained as the trifluoroacetate salts 
following purification by HPLC. Full synthetic procedures and 
characterization of the compounds is provided in the Supporting 
Information. 
 
Thermal melting assays 
With the ligand series in hand, we initially sought to evaluate and 
compare their ability to stabilize a variety of G-quadruplex and 
duplex DNA structures alongside previously reported compounds 
by means of a fluorescence-based thermal melting assay.[20] 
Briefly, the DNA sequences of interest are conjugated to a 
fluorescence donor (FAM) and to an acceptor (TAMRA) at the 3’ 
and 5’ ends, respectively. When folded into secondary structures, 
the proximity of the donor and acceptor results in quenching of 
the donor fluorescence by energy transfer (FRET) to the acceptor. 
Upon raising the temperature, the secondary structure denatures 
causing the acceptor and donor to move apart, observed as an 
increase in donor fluorescence. The resulting curves (ESI, 
Figures S1-S5) indicate the characteristic melting temperature 
(Tm) of the sequence. Ligands that stabilize the folded structure 
cause the Tm to increase relative to that of the sequence without 
added ligand. The resulting difference in melting temperature 
(ΔTm) indicates the ability of the ligand to stabilize the folded 
structure (See ESI for full details of the experimental protocol). 
New ligands 3-5 were evaluated in this assay against the 
telomeric sequence F21T in potassium and sodium buffers and 
the FmycT sequence in potassium buffer. A duplex DNA hairpin 
(F10T) was also included to assess the ability of the ligands to 
discriminate between the different types of DNA secondary 
structure. Furthermore, all ligands 1-5 were screened against the 
newly-available Febr1T G4 sequence found in the genome of T. 
brucei.[9] ΔTm values for all ligands (at 5 μM concentration) are 
displayed in Table 1, and dependence of ΔTm on ligand 
concentration is displayed in Figure 2a for the potassium form of 
F21T, the sequence for which the ligands appear to be most affine. 
Concentration-dependence curves for the other DNA sequences 
are provided in the ESI (Figures S6-S9). 
  
Table 1. Thermal stabilization (ΔTm) induced in G4 and duplex DNA by 5  
μM ligands 1-5.[a] 
 ΔTm /  °C 
Ligand F21T K+ F21T Na+ FmycT Febr1T F10T 
1[b] 33 26 29 22 5 
2[b] 21 13 18 9 3 
3 28 19 30 17 3 
4 6 0 5 4 0 
5 0 0 0 2 0 
[a] F21T=5’-FAM-GGGTTAGGGTTAGGGTTAGGG-TAMRA-3’; 
FmycT=5′‐FAM‐TTGAGGGTGGGTAGGGTGGGTAA‐TAMRA‐3′; Febr1T= 
5’-FAM-GGG-CAG-GGG-GTG-ATG-GGG-AGG-AGC-CAG-GG-TAMRA-
3’; F10T=5′‐FAM‐TATAGCTATA‐HEG‐TATAGCTATA‐TAMRA‐3.′ The 
DNA concentration was 0.2  μM. Representative melting curves and error 
bars are showin in the ESI (Figures S1-S5) [b] ΔTm values for ligands 1 and 
2 against F21T, FmycT and F10T were reported previously.[17] 
  
 
Figure 2. (a) Dependence of ΔTm of F21T (K+) on concentration of each 
ligand. Owing to high ligand fluorescence, the ΔTm ligand 3 could not be 
extracted above 5 μM (b) Retained thermal stabilization of F21T K+ by 1 μM 
ligands 1-3 in the presence of increasing concentrations of ds26, a 
competitor duplex DNA hairpin. 
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From our initial screen, the most striking feature is that the 
pyridiunium ligand class (1-3) show superior binding when 
compared to the flexible methylpiperazine-derived ligands (4-5). 
For example, ligand 4 only displays significant stabilization in the 
quadruplex sequences at 5 μM ligand concentration and above, 
whilst all three pyridinium derivatives 1-3 remain potent down to 1 
μM ligand concentration (Figure 2a and ESI, Figure S6-S8).  
Given that many potent G4 ligands, such as the well-explored 
naphthalene diimide family, feature flexible basic side-chains of 
the type exemplified by 4 and 5,[18,19,21] it is somewhat a surprising 
finding that such a design feature does not appear to confer high 
G4 stabilizing ability to the stiff-stilbene scaffold, despite this core 
displaying a clear ability to serve as the basis of selective G4 
ligands as exemplified by compounds 1-3. Compounds in the NDI 
 
 
Figure 3: Circular dichroism and UV-visible titrations of ligands 1, 2, 3. (a,c,e) CD spectra of telo23 (4.2  μM, black traces) titrated 0 (black trace) to 7 (dark grey 
trace) eq. ligands (a) 1, (c) 2 and (e) 3. Intermediate titration points are shown in light grey. Induced CD signals in the ligand regions are marked with a square 
bracket. (b,d,f,) UV-visible spectra of ligands (b) 1 (d) 2 (f) 3 (10 μM) titrated with telo23. The insets show filling of the data to independent and equivalent sites 
binding models to yield the dissociation constants. Data for compound 1 were reported previously.[17] 
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series functionalized with alkyl chains bearing methyl piperazine 
termini have been found to bind G4 by forming stacking 
interactions between the NDI core and external tetrads of the G4, 
with the basic side chains residing in the G4 grooves.[19] The 
comparatively poor performance of the stiff-stilbene analogues of 
these compounds suggests this scaffold is comparatively 
ineffective at achieving such a binding mode and perhaps the high 
stabilization displayed by ligands 1-3 may originate from 
alternative binding modes, such as targeting G4 grooves (vide 
infra). 
Both Z ligands (2 and 5) are comparatively weak G4 binders in 
comparison to their E counterparts. Whilst the E ligand 4 induces 
appreciable stabilization in the potassium form of F21T K+ (ΔTm 
at 5 μM = 6 °C), Z isomer 5 induces a negligible stabilization at 
the same concentration. A similar effect was previously observed 
for ligands 1 and 2. Given the significantly different molecular 
geometries configurations of the Z and E stiff stilbene core, these 
results suggest that the olefin configuration of the central scaffold 
is critical in determining the activity in this class of compound 
independent of the nature of the lateral groups. Meanwhile, the 
ΔTm values observed for pyridinium ligand 3 are in general 
significantly lower than those for compound 1. This suggests that 
the more compact arrangement of 1 proves superior for G4 
binding when compared with the extended linear configuration of 
ligand 3.  
It is important to highlight that all ligands 1-5 induce only negligible 
to minor stabilization on the duplex DNA model F10T at 
concentrations that induce significant stabilization of G4. This 
indicates the stiff-stilbene scaffold possesses an inherent 
selectivity for binding to G4 over duplex sequences. Given the 
particularly high activity of compounds 1-3, we were keen to verify 
the observed selectivity of these compounds through means of a 
competition experiment in which the effect of increasing 
concentrations of unlabelled duplex DNA (ds26) on the ΔTm of the 
G4 sequences is measured. Under such conditions, off-target 
binding is observed as reduction in the ΔTm value relative to that 
obtained in the absence of the competing species. All three 
pyridinium ligands 1-3 discriminate most effectively between the 
F21T K+ sequence and duplex DNA (Figure 2b). Even at 25 molar 
equivalents of ds26, over 50% of the thermal stabilization induced 
by ligands 1-3 is retained for this sequence. The ligands appear 
to be significantly less selective against the same sequence in 
sodium-containing buffer (ESI, Figure S10), particularly ligand 2, 
where the thermal stabilization induced by the ligand is lost 
entirely at 12.5 molar equivalents of ds26 competitor and above. 
This behavior is reflective of the lower affinity of the ligands for 
F21T in sodium-containing buffer observed in Table 1. Both 
ligands 1 and 3 (the more potent G4 ligands) retain over 50% of 
the induced thermal stabilization of the FmycT sequence (ESI, 
Figure S11) at 25 molar equivalents of ds26, confirming a high 
degree of selectivity for these ligands. On the other hand, ligand 
2 is again less selective, and a gradual erosion of the induced 
stabilization on increasing the concentration of duplex competitor 
is observed. Against the FebrT found in the T. brucei genome, 
ligand 1 outperforms ligands 2 and 3 for selective targeting of the 
G4 structure over duplex DNA (ESI, Figure S12). Taken together, 
the results of Table 1 and the competition assays across the panel 
of G4s, compound 1 emerges as the lead compound in the series 
in terms of both the magnitude of the induced thermal stabilization 
of G4, and its general selectivity for G4 DNA in favor of double-
stranded secondary structure. 
Circular dichroism spectroscopy and UV-visible titration 
studies 
In order to further examine the nature of interaction of ligands 1-5 
with G4 topologies, we employed a combination of circular 
dichroism (CD) spectroscopy and UV-visible titration studies 
(techniques commonly used for the study G4/ligand 
interactions).[22] Both approaches have the advantage that 
modification of the oligonucleotide sequence with artificial 
fluorophores is not necessary, allowing validation of binding 
effects against natural sequences where the folding topology is 
well-validated by structural studies. These studies therefore allow 
inference of possible binding modes along with quantification of 
binding affinity in physiologically-relevant conditions. Prior to 
undertaking these studies, we first validated that all ligands were 
stable to photoisomerization/photodegradation under the assay 
conditions (ESI, Figure S13). In this study, we chose to first 
examine the binding of the ligands to the hybrid (telo23, 
potassium) form of the telomeric sequence,[23] since this 
sequence occurs in both human and parasitic genomes and is the 
most relevant topology of this G4 in vivo owing to the high 
concentration of potassium inside cells.[24]  
The circular dichroism spectrum of telo23 is characterized by a 
positive band at 290 nm, and a weaker shoulder band at 260 nm 
indicative of a predominant hybrid G4 topology.[25] Binding of the 
pyridinium derivatives 1-3 is evidenced by hyperchromicity in the 
positive band at 290 nm (Figure 3a, 3c and 3e) and the increased 
intensity the negative band at 240 nm. The effect is most striking 
for compound 1 (as previously reported[17]) consistent with this 
compound being the more potent of the three pyridinium ligands 
investigated in the current study. These changes indicate an 
overall stabilization of the native G4 fold by compound 1. However, 
whilst the 260 nm shoulder band is preserved upon titration with 
ligand 1 (Figure 3a), this band disappears upon titration with 
 
Table 2. Apparent ligand/telo23 dissociation constants from UV-titration 
experiments[a] 
Ligand Kd / μM Ligand:G4[b] 
1 0.4 3 
2 70 2 
3 2 3 
4 70 1 
5 n.d.[c] n.d.[c] 
[a] For full details and data, see ESI, [b] number of ligand binding sites 
assumed in binding model, [c] Kd too weak for accurate determination. 
 
10.1002/chem.201905753
A
cc
ep
te
d 
M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
FULL PAPER    
 
 
 
 
 
ligand 2 (Figure 3c), suggesting a shift in folding equilibrium in 
favor of an alternative G4 topology. Whilst it is not possible to 
draw detailed conclusions from CD data alone, subsequent NMR 
studies (vide infra) indicate that the equilibrium mixture of major 
and minor species formed by telo23 under the experimental 
conditions shifts to favor a single species on addition of ligand 2. 
The CD spectral features present in the telo23/ligand 2 complex 
are superficially representative of an antiparallel-folded G4, but 
more detailed studies are necessary to truly establish the precise 
structure of the telo23/2 complex. Only very weak induced CD 
signals are observed in the ligand region for compound 3, in 
contrast to the more evident induced CD signals induced by ligand 
1, suggesting that whilst ligand 1 binds through groove binding 
modes,[17,26] end stacking modes are available for ligand 3. Lesser 
(though still significant) spectral perturbations were observed for 
ligand 4 (ESI, Figure S13a) indicating the weaker affinity of this 
ligand for G4. No perturbation of the CD spectra of telo23 was 
observed for ligand 5 (ESI, Figure S13b), corroborating the results 
from the FRET assay which indicated no stabilization of G4 was 
observed over the range of concentrations studied. 
Quantification of the binding affinity of ligands 1-5 to hybrid G4 
was performed using UV-visible titration studies. The resulting 
titrations and representative isotherms are shown in Figures 3b, 
3d and 3f, and ESI (Figures S15-S19) in which the absorbance 
spectrum of the ligand was measured upon titration with telo23 
G4. Apparent binding isotherms and stoichiometries were 
determined by fitting the observed hyperchromic shifts to an 
independent-and-equivalent-sites binding model (see ESI).[27,28] 
Strikingly, the observed affinities mirror the trends observed in the 
thermal melting assays, with compound 1 again emerging as the 
most potent G4 ligand. Ligand 5, which displayed negligible effect 
on the stability of G4 induced only subtle perturbations to the UV 
spectra of telo23 were observed (ESI, Figure S19), indicating 
weak interaction and meaning the dissociation constant could not 
be reliably determined. These results confirm that the critical 
nature of the stilbene configuration in G4 recognition, with E 
compounds 1 and 3 exhibiting micromolar G4 affinity, whilst Z 
ligand 2 displays affinity two orders of magnitude lower. Notably, 
a striking bathochromic shift (approximately 30 nm) is observed 
in the spectrum of ligand 3 (Figure 3f). This effect is indicative that 
an end-stacking ligand binding mode is present, where the energy 
of the π- π* transition responsible for the Soret band is lowered 
by the interaction of the ligand chromophore with the G-tetrad.[29] 
Such marked shifts are not observed for related ligand 1, where 
the CD data is indicative of groove binding modes.[17] 
To further investigate the G4/duplex selectivity observed for lead 
compound 1, we undertook a further titration study of this 
compound with duplex DNA (ds26) in order to examine the origin 
of the selectivity between the two DNA species observed in the 
FRET assay (Figure S20). Changes in the UV-region of the ligand 
1 absorbance spectrum also occur upon titration with ds26, albeit 
to a lesser degree than with the G4 species. We propose these 
perturbations arise from electrostatic interactions between the 
cationic ligand and the negatively-charged DNA-phosphate 
backbone, which are likely to be relatively independent of DNA 
secondary structure when compared to specific steric binding 
modes. More strikingly, the induction of hyperchromicity in the 
shoulder band in the visible region of the ligand spectrum 
(centered on 430 nm) by telo23, is barely observed upon titration 
with duplex DNA (Figure 4). Therefore, it appears that the telo23 
G4 provides a further ligand binding mode that is not accessible 
in the duplex sequence. We propose that this structure-specific 
binding mode is responsible for the overall G4 selectivity 
observed in the melting assays.  
 
 
Figure 4: 430 nm binding isotherms for ligand 1 titrated with 
telo23 G4 and ds26 duplex DNA sequences showing the 
availability of a specific binding mode to G4 that is not available 
for duplex DNA. 
 
 
NMR studies 
 
To provide initial structural insights into the data obtained in the 
UV-visible and circular dichroism titration experiments, and 
provide preliminary validation of the proposed binding modes of 
ligands 1-3 to telo23 G4, we undertook 1D 1H imino NMR 
experiments (Figure 5). Spectra were interpreted using 
assignments of the resonances of the major hybrid-fold species 
previously reported by Patel et al.[23] Significant line broadening of 
the imino resonances can be observed upon titration with ligand 
1 (Figure 5b). Such broadening effects could be attributed to the 
strong binding of this ligand, resulting in intermediate-to-slow 
exchange between free and bound ligand states on the NMR 
timescale. All imino signals broaden to a similar degree and 
remain distinguishable, suggesting interactions with specific G-
tetrad residues do not dominate in the association of ligand 1 with 
G4, providing additional evidence for the groove binding mode 
inferred from the CD titrations. Ligand 3 (Figure 5d) also induces 
spectral line broadening, though signals associated with the lower 
G-tetrad (G15/G23) disappear entirely, suggesting stacking (or 
possibly intercalative) interactions with this part of the G4 are 
important in the binding of ligand 3. Meanwhile, line broadening is 
much less significant for ligand 2. This ligand binds more weakly 
to the G4 (vide supra) and therefore faster exchange between 
bound and unbound ligand states on the NMR timescale can be 
expected. This allows significant chemical shift perturbations to 
be observed in the imino resonances of the G4 upon addition of 
the ligand, indicating this ligand may also interact with the G4 
target through association with the G-tetrads. Interestingly, while 
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the unbound G4 sequence exists as a mixture of major and minor 
conformations, complexation with ligand 3, appears to favor a 
single conformation, with only 12 distinct imino signals visible at 
2:1 stoichiometry (indicated in Figure 5c) versus the more 
complex spectrum for the G4 sequence in the absence of the 
ligand, which represents a mixture of majora and minor folded 
species as previously reported.[23] This structural perturbation 
may explain the disappearance of the shoulder band in the CD 
spectrum of telo23 upon titration with ligand 3. In conjunction with 
the data obtained in the CD and UV-visible titrations, we infer that 
ligand 1 does interact primarily through groove binding whilst 
stacking interactions are more important in the binding of ligands 
2 and 3. 
  
Toxicity studies 
Having demonstrated a range of binding affinities for stiff-stilbene 
G4 ligands 1-5 to G4 DNA, we were keen to make an initial 
assessment of the performance of these compounds as 
therapeutic agents. In particular, we were interested to examine 
whether the in vitro biological activity of the compounds correlated 
with their DNA binding properties. We measured the viability of 
parasitic and mammalian cell cultures in the presence of 
increasing doses of compounds 1-5. Activity was first measured 
against both T. brucei and L. major, with MRC-5 cell lines chosen 
as non-tumoral cell model for comparison. To our delight, 
compounds 1-5 exhibited a striking potent toxicity to T. brucei with 
EC50 values in the nanomolar range for all compounds (Table 3 
and ESI, Figure S21). Critically, the compounds are significantly 
less toxic against the non-tumoral MRC-5 cells with selectivity 
index of up to 700-fold, suggesting a promising therapeutic 
window for these compounds as anti-trypasanomal agents. 
However, the fact that ligand 5 also exhibits high toxicity despite 
its poor affinity for G4 suggests the mechanism of toxicity is 
unlikely to be related to G4 recognition in the case of this 
organism. Further studies are underway to investigate the origin 
of the high selectivity index of these compounds for T. brucei, 
which are significantly higher than those observed in related 
studies.[9,16] Though the compounds appear to exert a lower 
 
 
Figure 5: NMR titration studies of telo23 in potassium-containing buffer with ligands 1-3. (a) cartoon representation of the major G4 species formed under the 
experimental conditions, (b-d) NMR spectra of telo23 in the absence of ligand and with increasing equivalents of ligand (b) 1, (c) 2, (d) 3. In figure (c) the 12 G-
tetrad imino resonances (indicating shift to a single conformation) are marked. In figure (d), the disappearance of G15/G23 signals (lower G-tetrad) are is 
indicated.    
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toxicity to the L. major parasite (Table 3 and ESI, Figure S22), 
ligands 1 and 3 demonstrated to have the strongest affinity for G4 
showing sub-micromolar efficacy against this organism, whilst the 
weaker G4 ligands (compounds 2, 4 and 5) are significantly less 
efficacious, suggesting a potential role for G4 recognition in their 
mechanism of action in this case. The selectivity index is 
significantly lower than observed in the case of T. brucei, but the 
values are comparable to those observed for other G4 ligands 
screened against this organism.[9]  
We next examined the potential of the compounds to serve as 
anticancer agents. At 3 day exposure, all compounds exhibited 
low toxicity (GI50 = 10-100 μM) to HeLa cervical cancer cells (ESI, 
Table S1 and Figure S23a). However, previous work by others 
has identified that a significantly longer exposure length to G4-
binding compounds is often necessary to observe toxic effects, 
since a mechanism of action involving telomere shortening 
theoretically requires several population doublings to take 
effect.[30] We therefore subjected both HeLa and MRC-5 cells to a 
longer-term (7 day) exposure of compounds 1-5 (Table 4 and ESI, 
Figures S22b and S23b). Strikingly, whilst the toxicity towards 
MRC-5 was comparable with that observed at shorter-term 
exposure (GI50 = 10-100 μM), the cancerous cells became 
significantly more susceptible to lower doses of compound 1 (GI50 
= 62 nM) which, as we demonstrated above, is the most potent 
G4 ligand in our compound series. Indeed, this increase in 
potency returns a selectivity index of 29 at long-term exposure. 
We rationalize that the fact that the toxicity to MRC-5 cells does 
not significantly depend on exposure time for 1 could be attributed 
to the telomerase negative nature of this cell line, and therefore 
less susceptible to effects of telomeric G4 binding ligands. This 
ligand therefore shows significant promise as the basis of a 
potential G4-mediated selective cancer therapeutic and is worthy 
of future extensive screening and mechanism of action studies. 
The toxicity of the weaker G4 ligands 2, 4 and 5 are comparable 
(within one order of magnitude) to the values observed at short-
term exposure. This indicates that whilst these compounds do 
elicit some cytotoxicity to mammalian cells, a long-term 
mechanism of action, as observed for ligand 1 is not present. This 
is perhaps explained by the relatively low G4 affinity of these 
compounds observed in the titration studies and thermal melting 
assays. Compound 3 also displayed significantly stronger toxicity 
to HeLa cells at long-term exposure, but its acute toxicity to MRC-
5 cells (retained on long-term exposure) yields only a very modest 
selectivity index of 4. We propose that the poor discrimination 
between the cancerous and non-cancerous cell lines might result 
from binding to duplex DNA, since the FRET assays determined 
this compound to be less selective for G4-DNA than ligand 1 
. 
Confocal microscopy 
   
Table 3. Viability assay data for ligands 1-5 against parasitic (T. brucei and L. major) cultures and non-tumoral (MRC-5) mammalian cells after 72h incubation[a] 
 
GI50 / μM 
Selectivity index  
GI50 (MRC5) / GI50 (parasite) 
Ligand MRC-5 T. brucei L. major T. brucei L. major 
1 3.1 ± 1 0.029 ± 0.0005 0.64 ± 0.1 110 4.8 
2 12 ± 1 0.043 ± 0.0001 11 ± 2 280 1.1 
3 0.35 ± 0.1 0.0061 ± 0.002 0.11 ± 0.03 60 3.2 
4 10 ± 1 0.036 ± 0.001 16 ± 0.4 280 0.6 
5 9.0 ± 1 0.012 ± 0.005 2.3 ± 0.07 750 3.9 
 [a] Measured by Alamar blue assay (MRC5, T. brucei) or MTT assay (L. major). See ESI for full details and dose-response curves 
   
  
Table 4.  Viability assay data for ligands 1-5 against tumoral (HeLa) and 
non-tumoral (MRC5) mammalian cells following 7-day incubation[a] 
 GI50 / μM Selectivity index 
 
GI50 (MRC5) / GI50 (HeLa) Ligand MRC5 (7d) HeLa (7d) 
1 1.8 ± 0.5 0.062 ± 0.01 29 
2 20 ± 5 5.2 ± 2 3.8 
3 0.46 ± 0.1 0.11 ± 0.03 4.2 
4 18 ± 0.5 16 ± 0.3 1.1 
5 3.2 ± 0.07 3.1 ± 2 1.0 
[a] Measured by Alamar blue assay. See ESI for full details and dose-
response curves. 
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As a step towards validating the mechanism of action of our 
compounds and more concretely the intracellular localization of 
the ligands within the cell lines studies, we examined the uptake 
of these compounds by mammalian cells and parasites through 
 
Figure 6. Fluorescence microscopy images of HeLa cells and T. brucei parasites after incubation with (respectively) 0.5 or 1 μM ligand 3 for (a, d) 30 min or 
(b, e) 120 min. Control (c) cells and (f) parasites are also displayed. Visualization panes from left to right: mitochondria (Mitotracker Red), ligand 3, nucleus 
(DAPI), co-localisation image, bright-field image. Scale bar: 20 μm (cells) and 5 μm (parasites). 
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microscopy studies. Unfortunately, lead compound 1 was not 
sufficiently fluorescent to visualize using this technique. We 
therefore undertook localization studies on compound 3, which 
has photophysical properties much better suited to visualization 
in cells (λem =  550 nm, ESI, Figure S25). After 30 min incubation 
at 37 °C, significant uptake of compound 3 in both T. brucei and 
HeLa cells was observed.  The ligand was mainly localized in the 
nucleolus and the cytoplasm of HeLa cells, and partially in the 
mitochondria (Figures 6a and 6b). In T. Brucei, ligand 3 was 
mainly found in the nucleus and the kinetoplast (Figures 4d and 
4e). Similar locations patters were observed at longer (2h) 
incubation times, in L. major and MRC5 cells (ESI, Figure S26). 
These results suggest that pyridinium stiff-stilbene G4-ligands 
can reach DNA harboring sites and therefore possibly target G4 
structures. 
Conclusions 
G4 nucleic acids continue to offer exciting potential as a target 
against a range of disease pathologies. However, no G4-targeting 
drug has reached the clinic to date. The identification and 
development of new ligand scaffolds that display promising 
bioactivities is highly in demand and will form the basis of new G4-
based drug discovery projects. We have examined a selection of 
the structural features  that govern the binding of a novel series 
of designed stiff-stilbene ligands to nucleic acid targets. We show 
that ligand 1 appears to have the optimal molecular configuration, 
electronics and substitution pattern for efficient G4 recognition 
amongst this first generation of compounds. Moreover, we have 
demonstrated 1 has a high level of selectivity for G4 structures, 
and anticipate this selectivity could be further improved through 
the development of subsequent generations of G4 binding 
molecules based on this emergent G4-binding chemotype. 
Furthermore, we have demonstrated for the first time the potential 
of the stiff-stilbene derivatives to demonstrate high toxicity both to 
parasitic organisms and cancerous cell lines, whilst remaining up 
to two orders of magnitude less toxic to a non-tumoral model. 
Critically, in the case of the cellular models, in vitro cytotoxicity to 
cancerous cells strongly correlates with G4 binding activity, and 
dose response times indicate long-term mechanisms of action 
that may include G4-mediated pathways such as telomerase 
inhibition. We believe this proof-of-concept study reveals 
intriguing activities that render stiff-stilbene compounds an 
exciting lead scaffold for DNA-targeted drug development. 
Towards this end, further investigations into the therapeutic 
mechanism of stiff-stilbene ligands is warranted in order to 
interrogate the true biological targets and obtain more conclusive 
evidence regarding the potential G4-mediated mode of activity. 
Efforts towards these goals are under active pursuit in our 
laboratory and progress will be reported in due course. 
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Stiff-stilbene has very recently 
emerged as a promising scaffold for 
the design of selective G-quadruplex 
DNA ligands. We demonstrate the 
importance of substituent chemistry 
and molecular geometry on the 
activity of this novel ligand series. The 
lead compound exhibits up to 700-fold 
selective toxicity to parasitic 
organisms and 30-fold selective 
toxicity to cervical cancer cells over a 
non-tumoral mammalian cell model. 
   
Author(s), Corresponding Author(s)* 
Page No. – Page No. 
Title 
 
  
 
 
 
  = 
Lead compound: 
K
d 
(G4 DNA)=
 
0.4 μM 
IC
50
 (HeLa) = 60 nM 
IC
50
 (T. brucei) = 30 nM 
IC
50
 (MRC5) = 2 μM 
E/Z configuration 
Substitution pattern 
Structural variation: 
10.1002/chem.201905753
A
cc
ep
te
d 
M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
